Fauna Bio Launches AI Platform to Accelerate Drug Discovery Inspired by Nature’s Most Resilient Species June 16, 2025
Kiin Bio Closes €1.9M in Funding to Launch AI-Powered Virtual Scientist Platform for Drug Discovery June 10, 2025
SandboxAQ Partners with Google Cloud to Optimize Large Quantitative Models for Biopharma and Beyond January 21, 2025
Biolevate Closes €6M Seed Funding to Transform Drug Discovery and Personalized Medicine with AI November 30, 2024
Phare Bio Awarded Up To $27M from ARPA-H to Accelerate AI-Powered Drug Discovery and Develop Critically Needed New Classes of Antibiotics October 1, 2024
Insilico Medicine Reports Positive Phase IIa Results For a First-in-Class Drug Treatment For Idiopathic Pulmonary Fibrosis Designed by Generative AI September 26, 2024
RevolKa Announces the Closing of a $1.7M Series A Extension Funding to Accelerate Drug-Discovery Programs August 30, 2024
Fauna Bio Launches AI Platform to Accelerate Drug Discovery Inspired by Nature’s Most Resilient Species June 16, 2025
Kiin Bio Closes €1.9M in Funding to Launch AI-Powered Virtual Scientist Platform for Drug Discovery June 10, 2025
SandboxAQ Partners with Google Cloud to Optimize Large Quantitative Models for Biopharma and Beyond January 21, 2025
Biolevate Closes €6M Seed Funding to Transform Drug Discovery and Personalized Medicine with AI November 30, 2024
Phare Bio Awarded Up To $27M from ARPA-H to Accelerate AI-Powered Drug Discovery and Develop Critically Needed New Classes of Antibiotics October 1, 2024
Insilico Medicine Reports Positive Phase IIa Results For a First-in-Class Drug Treatment For Idiopathic Pulmonary Fibrosis Designed by Generative AI September 26, 2024
RevolKa Announces the Closing of a $1.7M Series A Extension Funding to Accelerate Drug-Discovery Programs August 30, 2024
